Cargando…
Modern treatment of retinoblastoma: A 2020 review
Retinoblastoma management remains complex, requiring individualized treatment based on International Classification of Retinoblastoma (ICRB) staging, germline mutation status, family psychosocial factors and cultural beliefs, and available institutional resources. For this 2020 retinoblastoma review...
Autores principales: | Ancona-Lezama, David, Dalvin, Lauren A, Shields, Carol L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774148/ https://www.ncbi.nlm.nih.gov/pubmed/33120616 http://dx.doi.org/10.4103/ijo.IJO_721_20 |
Ejemplares similares
-
Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions
por: Garza-Garza, Lucas A., et al.
Publicado: (2020) -
Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras
por: Camp, David A, et al.
Publicado: (2019) -
Malignant transformation of choroidal nevus according to race in 3334 consecutive patients
por: Marous, Charlotte L, et al.
Publicado: (2019) -
Retinoblastoma in older patients: A retrospective comparative analysis of 100 consecutive patients based on age
por: Masoomian, Babak, et al.
Publicado: (2019) -
Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma
por: Dalvin, Lauren A
Publicado: (2022)